Abstract:Background. Long noncoding RNAs (lncRNAs), which have little or no ability to encode proteins, have attracted special attention due to their potential role in cancer disease. We aimed to establish a lncRNA signature and a nomogram incorporating the genomic and clinicopathologic factors to improve the accuracy of survival prediction for laryngeal squamous cell carcinoma (LSCC). Methods. A LSCC RNA-sequencing (RNA-seq) dataset and the matched clinicopathologic information were downloaded from The Cancer Genome Atlas (TCGA). Using univariable Cox regression and least absolute shrinkage and selection operator (LASSO) analysis, we developed a thirteen-lncRNA signature related to prognosis. On the basis of multivariable Cox regression analysis results, a nomogram integrating the genomic and clinicopathologic predictors was built. The predictive accuracy and discriminative ability of the inclusive nomogram were confirmed by calibration curve and a concordance index (C-index), and compared with the TNM staging system by C-index and receiver operating characteristic (ROC) analysis. Decision curve analysis (DCA) was conducted to evaluate the clinical value of our nomogram. Results. Thirteen overall survival- (OS-) related lncRNAs were identified, and the signature consisting of the selected thirteen lncRNAs could effectively divide patients into high-risk and low-risk subgroups, with area under curves (AUC) of 0.89 (3-year OS) and 0.885 (5-year OS). Independent factors derived from multivariable analysis to predict survival were margin status, tumor status, and lncRNA signature, which were all assembled into the nomogram. The calibration curve for the survival probability showed that the predictions based on the nomogram coincided well with actual observations. The C-index of the nomogram was 0.82 (0.77-0.87), and the area under curve (AUC) of the nomogram in predicting overall survival (OS) was 0.938, both of which were significantly higher than the traditional TNM stage. Decision curve analysis further demonstrated that our nomogram had larger net benefit than TNM stage. Conclusion. An inclusive nomogram for patients with LSCC, comprising genomic and clinicopathologic variables, generates more accurate estimations of the survival probability when compared with TNM stage alone, but more data are needed before the nomogram is used in clinical practice.

Nomograms for predicting prognostic value of combined neutrophil-to-lymphocyte ratio and SCC-Ag in locally advanced cervical cancer

A Nomogram Predicting the Prognosis of Renal Cell Carcinoma Patients with Lung Metastases

The Prognostic Value Of Lymph Node Ratio In Patients With N2 Stage Lung Squamous Cell Carcinoma: A Nomogram And Heat Map Approach.

Nomograms combining computed tomography-based body composition changes with clinical prognostic factors to predict survival in locally advanced cervical cancer patients

Development and validation of prognostic nomographs for patients with cervical cancer: SEER-based Asian population study

A Genomic-Clinicopathologic Nomogram Predicts Survival for Patients with Laryngeal Squamous Cell Carcinoma

Nomograms Combining Clinical and Imaging Parameters to Predict Recurrence and Disease-free Survival after Concurrent Chemoradiotherapy in Patients with Locally Advanced Cervical Cancer

Increased CYFRA 21-1, CEA and NSE Are Prognostic of Poor Outcome for Locally Advanced Squamous Cell Carcinoma in Lung: A Nomogram and Recursive Partitioning Risk Stratification Analysis

Development and validation of nomogram models for predicting postoperative prognosis of early-stage laryngeal squamous cell carcinoma

Development of Comprehensive Nomograms for Evaluating Overall and Cancer-Specific Survival of Laryngeal Squamous Cell Carcinoma Patients Treated with Neck Dissection

Prognostic Nomograms to Predict Positive Lymph Nodes in Breast Cancer Patients after Neoadjuvant Chemotherapy: Competing Risk Models Basing on the SEER Database

A clinical nomogram based on absolute count of lymphocyte subsets for predicting overall survival in patients with non-small cell lung cancer

Preoperative peripheral blood neutrophil-to-lymphocyte ratios (NLR) and platelet-to-lymphocyte ratio (PLR) related nomograms predict the survival of patients with limited-stage small-cell lung cancer

A prognostic nomogram integrating novel biomarkers identified by machine learning for cervical squamous cell carcinoma

Accurate nomograms with excellent clinical value for locally advanced rectal cancer

[Development and validation of nomogram for predicting prognosis of patients with laryngeal squamous cell carcinoma after surgery].

Cmar_a_216532 9427..9437

Prognostic nomograms for locally advanced cervical cancer based on the SEER database: Integrating Cox regression and competing risk analysis

Development And Validation Of Nomogram To Predict Risk Of Survival In Patients With Laryngeal Squamous Cell Carcinoma

Nomograms for Predicting Long‐term Overall Survival and Cancer‐specific Survival in Lip Squamous Cell Carcinoma: A Population‐based Study

A nomogram of preoperative indicators predicting lymph vascular space invasion in cervical cancer